Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative medications function by mimicking the natural actions of GLP-1, a hormone secreted by https://bookmarklayer.com/story20817421/reta-glucagon-like-peptide-1-receptor-agonists